CDK12 loss drives prostate cancer progression, transcription-replication conflicts, and synthetic lethality with paralog CDK13
Jean C. Tien(University of Michigan), Arul M. Chinnaiyan(University of Michigan)
Cited by 27
Related Papers
Molecular Ordering of the Cell Death Pathway
|Journal of Biological Chemistry|1996|585
Targeting SWI/SNF ATPases in enhancer-addicted prostate cancer
|Nature|2021|311
Molecular Cross-talk between the TRAIL and Interferon Signaling Pathways
|Journal of Biological Chemistry|2002|100